500
Participants
Start Date
March 1, 2019
Primary Completion Date
August 31, 2021
Study Completion Date
September 30, 2021
Next-Generation Sequencing
In 500 patients with suspected or proven sepsis or septic shock (according to the Sepsis-3 definitions), patients´ characteristics and routine blood parameters will be determined at sepsis onset as well as 72 hours afterwards. At the same time points, 2 sets of blood cultures and one blood tube for Next-Generation Sequencing (NGS)-diagnostics will be collected. An evaluation of outcome will be performed at 28 days after sepsis onset.
Evangelisches Krankenhaus Luckau gGmbH, Luckau
University of Rostock, Rostock
Klinikum Bremerhaven Reinkenheide gGmbH, Bremerhaven
Medical School Hannover, Hanover
Evangelisches Krankenhaus Bethel gGmbH, Bielefeld
University Medical Center Göttingen, Göttingen
Duesseldorf University Hospital, Düsseldorf
University Hospital Essen, Essen
RWTH Aachen University, Aachen
University Hospital Frankfurt, Frankfurt
University Hospital Heidelberg, Heidelberg
University Hospital Tübingen, Tübingen
Klinikum Mittelbaden Baden-Baden Balg, Baden-Baden
University Hospital rechts der Isar, Munich
Ulm University Medical Center, Ulm
University Hospital of Regensburg, Regensburg
Charité - Universitätsmedizin Berlin, Berlin
University Hospital Bonn, Bonn
University Hospital Köln, Cologne
Kliniken Landkreis Heidenheim gGmbH, Heidenheim
University Hospital Leipzig, Leipzig
Fraunhofer Institute for Interfacial Engineering and Biotechnology
OTHER
Dietmar Hopp Stiftung GmbH
UNKNOWN
University Hospital Heidelberg
OTHER